Author:
Illa Isabel,de la Torre Carolina,Rojas-Garcia Ricardo,Altes Antoni,Blesa Rafael,Sierra Jordi,Gallardo Eduard
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Reference10 articles.
1. Feasel AM, Donato ML, Duvic M. Complete remission of scleromyxedema following autologous stem cell transplantation. Arch Dermatol.2001;137: 1071-1072.
2. Lacy MQ, Hogan WJ, Gertz MA, et al. Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation. Arch Dermatol.2005;141: 1277-1282.
3. Donato ML, Feasel AM, Weber DM, et al. Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation. Blood.2006;107: 463-466.
4. Ferrarini M, Helfrich DJ, Walker ER, Medsger TA Jr, Whiteside TL. Scleromyxedema serum increases proliferation but not the glycosaminoglycan synthesis of dermal fibroblasts. J Rheumatol.1989;16: 837-841.
5. Harper RA, Rispler J. Lichen myxedematosus serum stimulates human skin fibroblast proliferation. Science.1978;199: 545-547.
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Severe cutaneous scleromyxedema treated by lenalidomide;JEADV Clinical Practice;2023-06-12
2. Stem cell therapy in dermatology;Indian Journal of Dermatology, Venereology and Leprology;2021-06-24
3. Scleromyxedema;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2020-12
4. Skleromyxödem;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2020-12
5. Scleromyxedema treatment: a systematic review and update;International Journal of Dermatology;2020-05-02